Exhaled ethane concentration in patients with cancer of the upper gastrointestinal tract - A proof of concept study

BioScience Trends

Volumn 3, Issue 3, 2009, Pages 110-114

  Abela, Jo Etienne ^a,b   Skeldon, Kenneth D ^c,d   Stuart, Robert C ^a   Padgett, Miles J ^d  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Esophageal cancer; Ethane gas; Gastric cancer; Laser spectroscopy; Oxidative stress

Indexed keywords

DIAGNOSTIC AGENT; ETHANE; TUMOR MARKER;

ARTICLE; BREATH ANALYSIS; COMPARATIVE STUDY; GASTROINTESTINAL TUMOR; HUMAN; LASER; METABOLISM; METHODOLOGY; SPECTROSCOPY; UPPER GASTROINTESTINAL TRACT;

BREATH TESTS; ETHANE; GASTROINTESTINAL NEOPLASMS; HUMANS; LASERS; SPECTRUM ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UPPER GASTROINTESTINAL TRACT;

EID: 77952560081     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Knight JA. Free radicals: their history, and current status in aging and disease. Ann Clin Lab Sci. 1998; 28:331-346.
2. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med. 1994; 17:127-160.
3. Gardner HW. Oxygen r a d i c a l c h e m i s t r y o f polyunsaturated fatty acids. Free Radic Biol Med. 1989; 7:65-86.
4. Frankel EN. Volatile lipid oxidation products. Prog Lipid Res. 1983; 22:1-33.
5. Meagher EA, Fitzgerald GA. Indices of lipid peroxidation: strengths and limitations. Free Radic Biol Med. 2000; 12:1745-1750.
6. Dumelin EE, Tappel AL. Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of performed hydroperoxides. Lipids. 1977; 12:894-900.
7. Skrzydlewska E, Kozuszko B, Sulkowska M, Bogdan Z, Kozlowski M, Snarska J, Puchalski Z, Sulkowski S, Skrzydlewski Z. Antioxidant potential in esophageal, stomach and colorectal cancers. Hepato-Gastroenterology. 2003; 50:126-131.
8. Terry P, Lagergren J, Ye W, Nyrén O, Wolk A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer. 2000; 87:750-754.
9. Polat MF, Taysi S, Gul M, Cikman O, Yilmaz I, Bakan E, Erdogan F. Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem Func. 2002; 20:327-331.
10. Choi MA, Kim BS, Yu R. Serum antioxidative vitamin levels and lipid peroxidation in gastric carcinoma patients. Cancer Lett. 1999; 136:89-93.
11. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, Gumus M. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol. 2002; 32:162-166.
12. Phillips M, Cataneo RN, Cummin AR, Gagliardi AJ, Gleeson K, Greenberg J, Maxfield RA, Rom WN. Detection of lung cancer with volatile markers in the breath. Chest. 2003; 123:2115-2123.
13. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, Finazzi-Agrò A, D'Amico A. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron. 2003; 18:1209-1218.
14. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem. 1985; 31:1278-1282.
15. Hietanen E, Bartsch H, Béréziat JC, Camus AM, McClinton S, Eremin O, Davidson L, Boyle P. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study. Eur J Clin Nutr. 1994; 48:575-586.
16. Phillips M, Cataneo RN, Ditkoff BA. Volatile markers of breast cancer in the breath. Breast J. 2003; 9:184-191.
17. Knutson MD, Handelman GJ, Viteri FE. Methods for measuring ethane and pentane in expired air from rats and humans. Free Radic Biol Med. 2000; 28:514-519.
18. Gibson G, Monk SD, Padgett M. A field-portable, laserdiode spectrometer for the ultra-sensitive detection of hydrocarbon gases. J Modern Opt. 2002; 49:769-776.
19. Skeldon KD, Gibson GM, Wyse CA, McMillan LC, Monk SD, Longbottom C, Padgett MJ. Development of high resolution real-time sub-ppb ethane spectroscopy and some pilot studies in life science. Appl Opt. 2005; 44:4712-4721.
20. Risby TH. Sehnert SS. Clinical application of breath biomarkers of oxidative stress status. Free Radic Biol Med. 1999; 27:1182-1192.
21. Dahnke H, Kleine P, Hering P Mürtz M. Real-time monitoring of ethane in human breath using mid-infrared cavity leak-out spectroscopy. Appl Phys B. 2001; 72:971-975.
22. Habib MP, Clements NC, Garewell HS. Cigarette smoking and ethane exhalation in humans. Am J Respir Crit Care Med. 1995; 151:1368-1372.
23. Paredi P, Kharitonov SA, Barnes PJ. Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med. 2000; 162:1450-1454.
24. van Beurden WJ, Dekhuijzen PN, Smeenk FW. Exhaled biomarkers in COPD: their potential role in diagnosis, treatment and prognosis. Monaldi Arch Chest Dis. 2002; 57:258-267.
25. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162:369-373.
26. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med. 2002; 166:S31-77.
27. Pelli MA, Trovarelli G, Capodicasa E, De Medio GE, Bassotti G. Breath alkanes determination in ulcerative colitis and Crohn's disease. Dis Colon Rectum. 1999; 42:71-76.
28. Sedghi S, Keshavarzian A, Klamut M, Eiznhamer D, Zarling EJ. Eleveated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. Am J Gastroenterol. 1994; 89:2217-2221.
29. Aghdassi E, Allard JP. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radic Biol Med. 2000; 28:880-886.
30. Toshniwal PK, Zarling EJ. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem Res. 1992; 17:205-207.
31. Phillips M, Erickson GA, Sabas M, Smith JP, Greenberg J. Volatile organic compounds in the breath of patients with schizophrenia. J Clin Path. 1995; 4:466-469.
32. Ross BM, McKenzie I, Glen I, Bennett CP. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci. 2003; 6:277-281.
33. Rieder J, Lirk P, Ebenbichler C, Gruber G, Prazeller P, Lindinger W, Amann A. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien Klin Wochenschr. 2001; 113:181-185.